- Home
- ARWR vs CAG Comparison
ARWR vs CAG Comparison
Compare ARWR & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | CAG |
|---|---|---|
| Founded | 2003 | 1919 |
| Country | United States | United States |
| Employees | N/A | 26100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 8.1B |
| IPO Year | 2009 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ARWR | CAG |
|---|---|---|
| Price | $55.13 | $16.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 14 |
| Target Price | ★ $81.50 | $19.29 |
| AVG Volume (30 Days) | 1.9M | ★ 12.0M |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.66% |
| EPS Growth | 99.80 | ★ 233.33 |
| EPS | ★ 0.22 | N/A |
| Revenue | $16,142,321.00 | ★ $1,500,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $249.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $15.96 |
| 52 Week High | $76.76 | $27.68 |
Technical Indicators
Market Signals| Indicator | ARWR | CAG |
|---|---|---|
| Relative Strength Index (RSI) | 30.90 | 32.68 |
| Support Level | $36.34 | $15.96 |
| Resistance Level | $66.37 | $19.54 |
| Average True Range (ATR) | 3.12 | 0.49 |
| MACD | -0.84 | -0.34 |
| Stochastic Oscillator | 8.07 | 11.21 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.